OEB 6: The new standard in high-potent molecule manufacturing?
In recent years, the pharmaceutical industry has seen a significant increase in the development of highly potent active pharmaceutical ingredients…
Partner Content
-
-
RWD and RWE are rewriting how we design and run trials
Traditional randomized controlled trials (RCTs) have long been the gold standard for testing new therapies, but they are increasingly strained…
-
A New Strategic Blueprint: Designing Smarter Early Phase Trials in Oncology
Cancer drugs form one of the most dynamic segments of pharmaceuticals, powered by rising incidence, ageing populations, deeper cancer biology,…
-
By the Numbers: Oncology Trial Activation Timelines and Global Reach
The volume of current activity in the oncology space is enormous. GlobalData’s clinical trial database – a repository of data…
-
Robots and pharma logistics: is the future inside a McKesson warehouse?
Across the pharmaceutical sector, governments in major markets are placing increasing pressure on the industry for full visibility and traceability…
-
Podcast: driving linked data insights, the complexities, and experiences
This is the final episode in season one of Insights Uncovered: A Real-World Data Podcast Series from GlobalData, presented by…
-
The importance of real-world evidence in transforming healthcare decision-making
Over the last 20 years, US healthcare has shifted to a value-based system, with payers and healthcare providers being challenged…
-
Advancing pharma fulfilment in 2026: is your software up to the challenge?
Pharmaceutical and healthcare fulfilment operations are under enormous pressure, with a need to navigate multiple supply chain challenges. Scalable systems…
-
Free webinar: Ensuring compliance-first logistics for reliable clinical trials
According to GlobalData, industry-sponsored trials have increased from 7,721 in 2016 to 13, 685 in 2025. This growth over the…
-
Innovations in Dermatology Trials: Embracing Digital Tools and Decentralized Approaches
Skin disease has a growing profile in drug development. New immuno-dermatology agents, topical biologics and cell-based treatments are moving through…